Skip navigation



Pioneering Study Reveals Brain Effects of Smoking Using Electronic Cigarettes

The results of a new study (published in the journal Scientific Reports) have demonstrated for the first time how the effects of “smoking” on the brain and nervous system can be monitored using functional MRI scanning. More »
22 September 2017

Report Calls for Increased Awareness of ctDNA Testing for Lung Cancer

A report published today by the PHG Foundation argues that limited awareness of validated ctDNA testing technology is restricting access to targeted therapy in a sub-group of patients with non-small cell lung cancer. More »
22 September 2017

Cambridge genomics pioneers celebrate 20 years of making science work for health

Tuesday 19 September saw PHG Foundation celebrate 20 years as pioneers for the use of genomics to improve health in the UK. The celebration took place at a gala dinner, held at Trinity College and attended by colleagues and friends of PHG Foundation Chair and founder, Dr Ron Zimmern. More »
21 September 2017

Synpromics Announces Gene Therapy Research Partnership with Solid Biosciences

Synpromics Ltd, the leader in gene control, today announces a new research partnership with Solid Biosciences, LLC. Under the terms of the agreement, Synpromics will provide Solid Biosciences access to a set of key muscle-selective promoter candidates to be used in the development of new treatment options for Duchenne muscular dystrophy (DMD). More »
20 September 2017

Glythera and IONTAS Enter Into License Agreement for the Development of Multiple Antibodies for Next-Generation ADC's

IONTAS will provide Glythera with antibodies from its fully human antibody libraries Glythera will use these antibodies, in combination with its novel toxin portfolio, to develop next generation ADCs with improved efficacy and safety, to target difficult-to-treat tumours More »
20 September 2017

Irvine Scientific Introduces Chemically-Defined Dendritic Cell Culture Medium for Immunotherapy Applications

Dendritic cells are a key contributor to developing cancer vaccines Irvine Scientific, a world leader in cell culture media development and manufacture, today announced the introduction of PRIME-XV® Dendritic Cell Maturation CDM, a chemically-defined, animal component-free medium for the differentiation of monocytes into immature dendritic cells, and subsequent maturation in dendritic cells. More »
19 September 2017

Cypralis granted new Innovate UK feasibility stage award to develop cyclophilin inhibitors targeting fibrotic diseases

Cypralis, a life sciences company focused on the discovery of therapeutics for the modulation of peptidyl-prolyl isomerases (PPIases), has been awarded new funding by Innovate UK, the UK’s innovation agency, under its BioMedical Catalyst competition. More »
18 September 2017

Horizon Discovery announces launch of genome-wide CRISPRi and CRISPRa screening services

Horizon a global leader in gene editing and gene modulation technologies, today announces that it has expanded its functional genomic screening portfolio to include first-to-market CRISPRi (interference) and CRISPRa (activation) screening services. More »
18 September 2017

Official launch of Global Regulatory Services' Swedish office

Monday 18 September 2017: Today Bobby and Greer Deal officially launch Global Regulatory Services Ltd in Lund, Sweden. More »
18 September 2017

High Force Research sets sights on North America

Leading North East-based chemical research and development company, High Force Research, is looking across the Atlantic as it sets its sights on growth More »
15 September 2017

<< Previous   Page 1 of 36   Next >>